Home › Mallinckrodt New Drug Application Granted Priority Review By FDA
 

Keywords :   


Mallinckrodt New Drug Application Granted Priority Review By FDA

2013-07-29 11:00:00| drugdiscoveryonline Home Page

Mallinckrodt recently announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for MNK-795 and granted priority review

Tags: review application drug priority

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Weekly Recap: PPG, Hempel, Beckers Group Top This Weeks Stories
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 3
29.06Tropical Storm Beryl Public Advisory Number 3
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 3
29.06Tropical Storm Beryl Forecast Advisory Number 3
29.06Eastern North Pacific Tropical Weather Outlook
More »